Elicad Pharmaceuticals Private Limited

Elicad Pharmaceuticals Private Limited - healthcare in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U74999GJ2018PTC100473 Incorporated 10 January 2018 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company healthcare DPIIT Startup MSME · Small
Data last updated
Revenue · FY 2026
₹12.55 Cr
▲ 30% YoY
Net profit · FY 2026
₹43.77 Lakh
Net margin 3.5%
EBITDA · FY 2026
₹67.58 Lakh
EBITDA margin 5.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹60 Lakh
Satisfied ₹10 Lakh
Company age
8 yrs
Est. 2018
Employees · EPFO
19
Provident fund records

About Elicad Pharmaceuticals Private Limited

Data last updated:

Elicad Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 10 January 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC100473. Its GSTIN is 24AAECE9032H1ZS (Gujarat).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gaurang Rohit Bhatt and Hiteshkumar Ramabhai Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Office No.911 Safal Prelude B/H Pinnacle Business Park Corporate Road Prahlad Nagar, Ahmedabad, Gujarat, India – 380015.

As per the financials filed for FY 2026, the company reported a revenue of ₹12.55 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹43.77 Lakh (net margin 3.5%) and EBITDA of ₹67.58 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 29% over five years.

The company has about 19 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹60 Lakh and satisfied charges of ₹10 Lakh on record.

Elicad Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0132607). For more details, the company can be reached via its website elicadpharma.com.

Company details

CIN U74999GJ2018PTC100473
Registration Number 100473
Incorporation Date 10 January 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0132607
Key People
Gaurang Rohit Bhatt Director Hiteshkumar Ramabhai Patel Director Nishit Vajubhai Ribadia Director

Recognitions & Rankings of Elicad Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0132607

Contact details

Elicad Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is elicadpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    elicadpharma.com
  • Registered Address
    Office No.911 Safal Prelude B/H Pinnacle Business Park Corporate Road Prahlad Nagar, Ahmedabad, Gujarat, India – 380015
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of Elicad Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Elicad Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Elicad Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Elicad Pharmaceuticals Private Limited, buy the company report.

Financials of Elicad Pharmaceuticals Private Limited

FY 2026 filings available

Elicad Pharmaceuticals Private Limited reported revenue of ₹12.55 Cr (up 30% YoY) for FY 2026.

Revenue · FY 2026
₹12.55 Cr ▲ 30%
Net profit · FY 2026
₹43.77 Lakh margin 3.5%
EBITDA · FY 2026
₹67.58 Lakh margin 5.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 28%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 2%
5 years · compounded
▲ 52%

Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 30% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations₹12.55 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹67.58 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹43.77 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin5.4%
Net Profit Margin3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Elicad Pharmaceuticals Private Limited, buy the company report.

Board of directors of Elicad Pharmaceuticals Private Limited

Elicad Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurang Rohit BhattDirector10 Jan 20188 Years 9 MonthsCurrent
Hiteshkumar Ramabhai PatelDirector10 Jan 20188 Years 9 MonthsCurrent
Nishit Vajubhai RibadiaDirector10 Jan 20188 Years 9 MonthsCurrent
Manoj Jayantilal BhayaniDirector10 Jan 20188 Years 9 MonthsCurrent
View all directors

Auditor

Elicad Pharmaceuticals Private Limited is audited by B H Mangarolia & Co. for the financial year 2026.

Auditor firmFinancial yearFirm registration number
B H Mangarolia & Co.FY 2026105972W

Shareholding

The shareholding of Elicad Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Elicad Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹60 Lakh
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Others₹0.60 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Feb 2022100545596Others₹60 LakhOpen
25 Feb 2019100242891Others₹10 LakhSatisfied

To see the full charge records of Elicad Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Elicad Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Value Chain Solutions (India) Private Limited
Antila Lifesciences Private Limited

To see the full MSME payment records of Elicad Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Elicad Pharmaceuticals Private Limited has a workforce of 19 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
19
Active EPFO establishments
1
Employee growth
5.56%

GST

Elicad Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAECE9032H1ZSGujaratActive15 Feb 2018

To see the full GST registrations and return filing status of Elicad Pharmaceuticals Private Limited, buy the company report.

Recent activity

Elicad Pharmaceuticals Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Manoj Jayantilal Bhayani ceased to be Managing Director on 10 Apr 2019.

Filing
Elicad Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
AGM
Elicad Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 60.00 Lakh with Charge ID 100545596 was registered on 25 Feb 2022.
Charges
A charge registered on 25 Feb 2019 via Charge ID 100242891 with Others was fully satisfied on 11 Feb 2022.
Ceased
Manoj Jayantilal Bhayani ceased to be Managing Director.
Ceased
Nishit Vajubhai Ribadia ceased to be Managing Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100242891 was registered on 25 Feb 2019.
Appointed
Gaurang Rohit Bhatt was appointed as Director.
Appointed
Hiteshkumar Ramabhai Patel was appointed as Director.
Appointed
Manoj Jayantilal Bhayani was appointed as Director.
Appointed
Nishit Vajubhai Ribadia was appointed as Director.
Incorporation
10 Jan 2018
Elicad Pharmaceuticals Private Limited was registered on 10 Jan 2018 with Roc Ahmedabad & aged 8 years 9 months as per MCA records.

Frequently asked questions

Elicad Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 10 January 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC100473.

Elicad Pharmaceuticals has 4 current directors:

The latest financial statements of Elicad Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Elicad Pharmaceuticals is 24AAECE9032H1ZS, registered in Gujarat.

The CIN (Corporate Identification Number) of Elicad Pharmaceuticals is U74999GJ2018PTC100473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elicad Pharmaceuticals was incorporated on 10 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Manoj Jayantilal Bhayani ceased to be Managing Director on 10 Apr 2019. Nishit Vajubhai Ribadia ceased to be Managing Director on 10 Apr 2019. Gaurang Rohit Bhatt was appointed as Director on 10 Jan 2018. Elicad Pharmaceuticals has 6 board changes on record in total.

Yes, Elicad Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Elicad Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0132607).

Elicad Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 4 overdue payments to 2 micro and small suppliers. The latest return was filed on 21 May 2019.

Elicad Pharmaceuticals can be reached through the website elicadpharma.com. Its registered office is in Ahmedabad, Gujarat, India.